PeloBiotech
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
www.pelobiotech.com<br />
• Low immunogenicity, reducing the risk of immune rejection when transplanted.<br />
Additionally, we offer a wide range of MSCs in research and GMP grade from various tissue sources, including canines,<br />
monkeys, dogs, mice, and humans, with different characteristics and applications, such as diseased models,<br />
conditionally immortalized cells, and those with GFP/RFP tags and cell RNA. For all of these MSCs we also offer<br />
corresponding media and tools.<br />
GMP MSCs<br />
We provide high-quality mesenchymal stromal cells (MSCs) for clinical and preclinical applications, offering<br />
both GMP and research-grade options. These cells are derived from 20 years of research and clinical experience<br />
at the Karolinska Institute, ensuring their quality. Our large-scale facility in Stockholm enables cost-effective<br />
production.<br />
• Adjustable quantity and vial size per dose.<br />
• Derived from bone marrow or adipose tissue of young, healthy volunteers.<br />
• Xeno-free and at Passage 3.<br />
• Offered with international delivery in liquid nitrogen.<br />
Exosomes<br />
These versatile cells cater to various research and clinical needs, with competitive pricing and delivery options<br />
for different requirements.<br />
Exosomes, small extracellular vesicles released by various cell types, have garnered significant attention for their diverse<br />
applications in both diagnostics and therapeutics. These tiny membrane-bound vesicles carry a cargo of proteins, nucleic<br />
acids, and lipids, facilitating intercellular communication. In diagnostics, exosomes serve as potential biomarkers for<br />
various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. Their non-invasive nature<br />
and specificity make them valuable in early disease detection. Moreover, exosomes hold promise in therapeutics, acting<br />
as natural delivery vehicles for drugs, RNA, or therapeutic proteins. Their ability to cross biological barriers, such as the<br />
blood-brain barrier, enhances their potential for targeted drug delivery. As research continues to unveil the intricate roles<br />
of exosomes, their applications are expanding, offering innovative solutions in personalized medicine and regenerative<br />
therapies.<br />
We offer exosomes produced from bone marrow mesenchymal stem cells which are CD9, CD63 and CD81 +ve,<br />
extensively tested and size and count verified by Zetaview.<br />
Also available are media (CellCor) and media supplements for exosome production using mesenchymal stem/stroma<br />
cells (see page 29-30).<br />
12
Change language